| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adipocyte fatty acid-binding protein (FABP4) as a potential biomarker for predicting metabolically driven low-grade and organ damage in thalassemia syndromes
|
Ezzat, Eman Mahmoud
|
|
|
103 |
9 |
p. 3473-3482
|
article
|
| 2 |
Advances in biology, diagnosis and treatment of DLBCL
|
Shi, Yuanfei
|
|
|
103 |
9 |
p. 3315-3334
|
article
|
| 3 |
Allogeneic stem cell transplantation is still a highly curative therapy in adults with philadelphia chromosome–positive acute lymphoblastic leukaemia
|
Hu, Lijuan
|
|
|
103 |
9 |
p. 3745-3754
|
article
|
| 4 |
Allogeneic stem cell transplant in primary hemophagocytic lymphohistiocytosis – a single-center experience
|
Hussain, Fayyaz
|
|
|
103 |
9 |
p. 3775-3782
|
article
|
| 5 |
A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis
|
Abu-Zeinah, Ghaith
|
|
|
103 |
9 |
p. 3573-3583
|
article
|
| 6 |
Artificial intelligence assisted diagnosis of chronic lymphocytic leukemia in a historic pediatric case using large language models
|
Fan, Bingwen Eugene
|
|
|
103 |
9 |
p. 3815-3819
|
article
|
| 7 |
Bortezomib elevates intracellular free Fe2+ by enhancing NCOA4-mediated ferritinophagy and synergizes with RSL-3 to inhibit multiple myeloma cells
|
Zhang, Yanyan
|
|
|
103 |
9 |
p. 3627-3637
|
article
|
| 8 |
CD56bright NK cell expansion correlated with EBV reactivation control post allogeneic hematopoietic stem cell transplantation
|
Juan, Xie
|
|
|
103 |
9 |
p. 3723-3735
|
article
|
| 9 |
CML in the very elderly: the impact of comorbidities and TKI selection in a real-life multicenter study
|
Rozental, Alon
|
|
|
103 |
9 |
p. 3585-3594
|
article
|
| 10 |
Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma
|
Pellegrino, Sara
|
|
|
103 |
9 |
p. 3713-3721
|
article
|
| 11 |
Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence
|
Li, Xiaoli
|
|
|
103 |
9 |
p. 3483-3491
|
article
|
| 12 |
Correction to: Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities
|
Budak, Betül
|
|
|
103 |
9 |
p. 3835
|
article
|
| 13 |
Correction to: SARS-CoV-2 infection-induced immune thrombocytopenia: a systematic review of current reports
|
Ono, Ryohei
|
|
|
103 |
9 |
p. 3837
|
article
|
| 14 |
Delphi consensus recommendations on treatment for advanced-stage marginal zone lymphoma in South Korea
|
Kim, Seok Jin
|
|
|
103 |
9 |
p. 3615-3625
|
article
|
| 15 |
De-novo ATR-16 syndrome associated with inherited hemoglobin Evanston causing HbH phenotype: a rare occurrence
|
Jajodia, Ekta
|
|
|
103 |
9 |
p. 3805-3810
|
article
|
| 16 |
Development of a clinical prognostic model for primary plasma cell leukemia patients treated with novel agents: a multicenter retrospective cohort study
|
Deng, Jingjing
|
|
|
103 |
9 |
p. 3691-3699
|
article
|
| 17 |
Disappearance of a chromosomal abnormality in a young patient with polycythemia vera treated with ropeginterferon alfa-2b
|
Hosoda, Rina
|
|
|
103 |
9 |
p. 3825-3827
|
article
|
| 18 |
Does R-EPOCH reduce the incidence of pulmonary embolism in cardiac lymphoma?
|
Shiroshita, Kohei
|
|
|
103 |
9 |
p. 3821
|
article
|
| 19 |
Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials
|
Tungjitviboonkun, Songphol
|
|
|
103 |
9 |
p. 3357-3368
|
article
|
| 20 |
Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis
|
Denk, Alexander
|
|
|
103 |
9 |
p. 3755-3764
|
article
|
| 21 |
Equitable access to polycythemia vera treatments: addressing reimbursement disparities in Europe
|
Breccia, Massimo
|
|
|
103 |
9 |
p. 3285-3286
|
article
|
| 22 |
ETV6::ABL1 positive myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK) with blast crisis treated with flumatinib mesylate
|
Chen, Fei
|
|
|
103 |
9 |
p. 3801-3804
|
article
|
| 23 |
Extramedullary and extranodal manifestations in chronic lymphocytic leukemia – an update
|
Robak, Tadeusz
|
|
|
103 |
9 |
p. 3369-3383
|
article
|
| 24 |
From treatment-centric to patient-centric: integrating social support and health assessments for better outcomes
|
Cui, Ying
|
|
|
103 |
9 |
p. 3823-3824
|
article
|
| 25 |
Hepatic, gastric and bone marrow AL amyloidosis that began with Budd-Chiari syndrome: a case report
|
Manieri, Valentina Maria
|
|
|
103 |
9 |
p. 3783-3786
|
article
|
| 26 |
Highlights of ophthalmological manifestations in newly diagnosed acute leukemia: a correlation with hematological parameters
|
Laimon, Dina N.
|
|
|
103 |
9 |
p. 3519-3533
|
article
|
| 27 |
Impact of different CEBPA mutations on therapeutic outcome in acute myeloid leukemia
|
Zhao, Yu
|
|
|
103 |
9 |
p. 3595-3604
|
article
|
| 28 |
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study
|
Leotta, Salvatore
|
|
|
103 |
9 |
p. 3701-3712
|
article
|
| 29 |
Inpatient outcomes of NSTEMI among patients with immune thrombocytopenia: a propensity matched national study
|
Baig, Mirza Faris Ali
|
|
|
103 |
9 |
p. 3443-3451
|
article
|
| 30 |
Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignancies
|
Du, Yanlu
|
|
|
103 |
9 |
p. 3765-3774
|
article
|
| 31 |
Lymphoma-associated hemophagocytic syndrome: a retrospective, single-center study of 86 patients
|
Cheng, Shijia
|
|
|
103 |
9 |
p. 3649-3656
|
article
|
| 32 |
Mutations of epigenetic modifier genes predict poor outcome in adult acute lymphoblastic leukemia
|
Ou, Jiawang
|
|
|
103 |
9 |
p. 3639-3648
|
article
|
| 33 |
Myeloproliferative neoplasms: young patients, current data and future considerations
|
Sobas, Marta
|
|
|
103 |
9 |
p. 3287-3291
|
article
|
| 34 |
Neurological involvement in hematopoietic stem cell transplantation-associated thrombotic microangiopathy
|
Liu, Wanying
|
|
|
103 |
9 |
p. 3303-3313
|
article
|
| 35 |
Obesity is associated with adverse outcomes in primary immune thrombocytopenia - a retrospective single-center study
|
Xiao, Zhengrui
|
|
|
103 |
9 |
p. 3453-3461
|
article
|
| 36 |
Outcomes of patients undergoing third hematopoietic cell transplantation for hematologic malignancies
|
Cox, Emily R.
|
|
|
103 |
9 |
p. 3737-3743
|
article
|
| 37 |
Overexpression of REC8 induces aberrant gamete meiotic division and contributes to AML pathogenesis - a multiplexed microarray analysis and mendelian randomization study
|
Hua, Wenxi
|
|
|
103 |
9 |
p. 3563-3572
|
article
|
| 38 |
Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a report of four cases
|
Wang, Qingwei
|
|
|
103 |
9 |
p. 3795-3800
|
article
|
| 39 |
Practical considerations in the management of patients treated with bosutinib for chronic myeloid leukemia
|
Lipton, Jeffrey H.
|
|
|
103 |
9 |
p. 3429-3442
|
article
|
| 40 |
Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis
|
Nagaharu, Keiki
|
|
|
103 |
9 |
p. 3535-3541
|
article
|
| 41 |
Prognostic impact of 1q abnormality on outcomes in patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone in a real-world clinical setting
|
Kikuchi, Taku
|
|
|
103 |
9 |
p. 3811-3813
|
article
|
| 42 |
Prophylaxis with Tixagevimab/Cilgavimab in chronic lymphocytic leukaemia, a case control study
|
Guarnera, Luca
|
|
|
103 |
9 |
p. 3831-3833
|
article
|
| 43 |
Rasburicase-induced hemolytic anemia and methemoglobinemia: a systematic review of current reports
|
Hammami, M Bakri
|
|
|
103 |
9 |
p. 3399-3411
|
article
|
| 44 |
Relationship between subtype-specific minimal residual disease level and long-term prognosis in children with acute lymphoblastic leukemia
|
Huang, Xiao-Tong
|
|
|
103 |
9 |
p. 3657-3665
|
article
|
| 45 |
Response to Dr. Ying Cui comments
|
Mulas, Olga
|
|
|
103 |
9 |
p. 3829
|
article
|
| 46 |
R2-ISS staging combined with circulating plasma cells improves risk stratification for newly diagnosed multiple myeloma: a single-center real-world study
|
Chu, Bin
|
|
|
103 |
9 |
p. 3677-3690
|
article
|
| 47 |
Safety and efficacy of L-Glutamine in reducing the frequency of acute complications among patients with sickle cell disease: A randomized controlled study
|
Ebeid, Fatma Soliman Elsayed
|
|
|
103 |
9 |
p. 3493-3506
|
article
|
| 48 |
Serum CXCL13 level is related to treatment response and predicts disease prognosis in Waldenström macroglobulinemia
|
Chen, Jia
|
|
|
103 |
9 |
p. 3667-3675
|
article
|
| 49 |
Socio-demographic determinants of myelofibrosis outcomes in an underserved center and the SEER national database
|
Yan, John
|
|
|
103 |
9 |
p. 3543-3551
|
article
|
| 50 |
Speckle tracking echocardiography and β-thalassemia major. A systematic review
|
Patsourakos, Dimitrios
|
|
|
103 |
9 |
p. 3335-3356
|
article
|
| 51 |
Superior detection of low-allele burden Janus kinase 2 V617F mutation and monitoring clonal evolution in myeloproliferative neoplasms using chip-based digital PCR
|
Lu, Yiyi
|
|
|
103 |
9 |
p. 3553-3562
|
article
|
| 52 |
TEMPI syndrome: difficult to diagnose, “easy” to treat?
|
Fotiou, Despina
|
|
|
103 |
9 |
p. 3787-3793
|
article
|
| 53 |
The advances of E2A-PBX1 fusion in B-cell acute lymphoblastic Leukaemia
|
Yang, Mengting
|
|
|
103 |
9 |
p. 3385-3398
|
article
|
| 54 |
The application of JAK inhibitors in the peri-transplantation period of hematopoietic stem cell transplantation for myelofibrosis
|
Wang, Zerong
|
|
|
103 |
9 |
p. 3293-3301
|
article
|
| 55 |
The effectiveness of the doxorubicin-etoposide-methylprednisolone regimen for adult HLH secondary to rheumatic disease
|
Yin, Dongfei
|
|
|
103 |
9 |
p. 3463-3472
|
article
|
| 56 |
The role of clonal progression leading to the development of therapy-related myeloid neoplasms
|
Guarnera, Luca
|
|
|
103 |
9 |
p. 3507-3517
|
article
|
| 57 |
The roles of ubiquitination in AML
|
Wei, Zhifeng
|
|
|
103 |
9 |
p. 3413-3428
|
article
|
| 58 |
Treatment of myelofibrosis with refractory anemia with luspatercept: a multicenter Chinese study
|
Wang, Leyu
|
|
|
103 |
9 |
p. 3605-3613
|
article
|
Journal description